Acta Pharmaceutica Sinica B
|
2026, 16(7): 4746-4747
• Commentaries •
Reprogramming the spleen-brain axis: Splenic monocyte/macrophage-mediated nanotherapy for ischemic stroke
Full
Xiaodi Shi1, Rabeya Jafrin Mow1, Chunhua Yang1,2
Affiliations
1 Institute for Biomedical Sciences, Center for Inflammation, Immunity & Infection, Digestive Disease Research Group, Georgia State University, Atlanta, GA 30303, USA;
2 Atlanta Veterans Affairs Medical Center, Decatur, GA 30033, USA
doi: 10.1016/j.apsb.2026.06.027
Outline
Macrophage reprogramming
/
Nanomedicine
/
Magnolol
/
Oxidative stress
/
PPARγ
/
CCR2/CCL2
Xiaodi Shi, Rabeya Jafrin Mow, Chunhua Yang.
Reprogramming the spleen-brain axis: Splenic monocyte/macrophage-mediated nanotherapy for ischemic stroke[J].
Acta Pharmaceutica Sinica B,
2026
, 16
(7)
: 4746
-4747
.
DOI: 10.1016/j.apsb.2026.06.027
Year 2026 volume 16 Issue 7
PDF
8
4
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2026.06.027